Biomaterials Research Group

Research Outline

Ultrasound theranostic devices
Our research activity aims to establish patient-friendly, effective and/or personalized medical treatments in the orthopedic and dental fields as well as in cancer through
  • development of new technology in biomaterial and regenerative medicine,
  • clinical translation thereof,
  • standards development thereof, and
  • guidance and draft guidance development thereof.
  • Members

    Name

    Research Topics

    G.S.

    Atsuo Ito ( Group leader )

    -Development of new calcium phosphate biomaterials
    -Development and translational research of growth factor combined medical devices
    -Development and translational research of cancer immunotherapy adjuvant
    -Regulatory science and draft guidance development on drug-combination medical devices

    G.S.

    Kazuo Onuma

    -Mineralization technology for rapid tooth repair
    -Mechanism of protein crystallization and its application to industry
    -Chemical mechanism of carcinogenesis and metastasis

    R

    G.S.

    Yoshimitsu Okazaki

    -Novel and biocompatible metallic implants
    -Design and process development for metallic custom-made implants
    -Regulatory science and guidance development on metallic implants
    -Standards development on metallic implants

    R

    Motohiro Hirose

    -Early estimation method for predicting later osteogenic differentiation activity of MSC
    -Regulatory science and guidance development on tissue-engineered medical products
    -Standards development on tissue-engineered medical products and cell-processing system

    R

    G.S.

    Yu Sogo

    -Development of new calcium phosphate biomaterials
    -Development of signal-molecule calcium phosphate composite coatings
    -Drug delivery using calcium phosphates
    -Development and translational research of growth factor combined medical devices

    R

    G.S.

    Xiupeng Wang

    -Development of new silicate and/or calcium phosphate biomaterials
    -Development of cancer immunotherapy adjuvant
    -Development of bone substitute materials

    R

    G.S.

    Mayu Yasunaga

    -Development of new calcium phosphate biomaterials
    -Development and translational research of growth factor combined medical devices
    -Development and translational research of cancer immunotherapy adjuvant
    -Regulatory science and draft guidance development on drug-combination medical devices

    G.S.

    Google Scholar:

    R

    ResearchID:


    Page Top

    Group Introductions